-10.90 (-0.92%) Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy's Laboratories announces agreement to acquire Mayne Pharma’s U.S. generic prescription product portfolio’.
The above information is a part of company’s filings submitted to BSE.